-transparent.png){kind=logo}
A child with myositis ossificans progressiva was treated for 8 years with ethane-1-hydroxy-1,1-diphosphonate (EHDP) 30-40 mg/kg per day. Latterly he complained of severe, progressive bone and joint pain which made standing and walking almost impossible. A radiographic skeletal survey showed diffuse ricket-like lesions. Withdrawal of EHDP therapy produced substantial improvement in his general condition as well as in the radiographic appearance of the bones. Multiple exostoses were observed in this case and, particularly those around the knees, presented a peculiar morphology. This supports the theory that exostoses originate from a defect of metaphyseal modelling.
Related Publications
U E Pazzaglia, and
G Beluffi, and
A Ravelli, and
G Zatti, and
A Martini
January 1986,
Microbiology and immunology,
U E Pazzaglia, and
G Beluffi, and
A Ravelli, and
G Zatti, and
A Martini
September 1976,
Ugeskrift for laeger,
U E Pazzaglia, and
G Beluffi, and
A Ravelli, and
G Zatti, and
A Martini
June 1974,
Calcified tissue research,
U E Pazzaglia, and
G Beluffi, and
A Ravelli, and
G Zatti, and
A Martini
September 1987,
Atherosclerosis,
U E Pazzaglia, and
G Beluffi, and
A Ravelli, and
G Zatti, and
A Martini
January 1972,
Lancet (London, England),
U E Pazzaglia, and
G Beluffi, and
A Ravelli, and
G Zatti, and
A Martini
June 1971,
Annals of internal medicine,
U E Pazzaglia, and
G Beluffi, and
A Ravelli, and
G Zatti, and
A Martini
January 1982,
Experimental pathology,
U E Pazzaglia, and
G Beluffi, and
A Ravelli, and
G Zatti, and
A Martini
September 1974,
Clinical science and molecular medicine,
U E Pazzaglia, and
G Beluffi, and
A Ravelli, and
G Zatti, and
A Martini
September 1973,
Experientia,
U E Pazzaglia, and
G Beluffi, and
A Ravelli, and
G Zatti, and
A Martini
January 1975,
Atherosclerosis,
